Search Results - "Chee, Y"

Refine Results
  1. 1

    Loop‐mediated isothermal amplification (LAMP): a versatile technique for detection of micro‐organisms by Wong, Y.‐P., Othman, S., Lau, Y.‐L., Radu, S., Chee, H.‐Y.

    Published in Journal of applied microbiology (01-03-2018)
    “…Summary Loop‐mediated isothermal amplification (LAMP) amplifies DNA with high specificity, efficiency and rapidity under isothermal conditions by using a DNA…”
    Get full text
    Journal Article
  2. 2

    The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis by Green, Nicole, Chan, Christopher, Ooi, Chee Y.

    Published in Pediatric pulmonology (01-09-2024)
    “…People with cystic fibrosis (pwCF) have an altered gastrointestinal microbiome. These individuals also demonstrate propensity toward developing small…”
    Get full text
    Journal Article
  3. 3

    Cystic fibrosis from the gastroenterologist's perspective by Ooi, Chee Y., Durie, Peter R.

    “…Key Points Cystic fibrosis is a life-limiting disease caused by different mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and…”
    Get full text
    Journal Article
  4. 4

    Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review by Ward, Anastasia, Mauleon, Ramil, Ooi, Chee Y., Rosic, Nedeljka

    Published in Human mutation (01-01-2024)
    “…Cystic fibrosis (CF) is a complex monogenic disorder with a large variability in disease severity. Growing evidence suggests that the variation observed…”
    Get full text
    Journal Article
  5. 5

    The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy by Garg, Millie, Ooi, Chee Y.

    Published in Current gastroenterology reports (01-02-2017)
    “…Purpose of Review Intestinal inflammation, dysbiosis, and increased gastrointestinal malignancy risks are well-described in patients with cystic fibrosis (CF)…”
    Get full text
    Journal Article
  6. 6

    Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis by Coffey, Michael J., Nielsen, Shaun, Wemheuer, Bernd, Kaakoush, Nadeem O., Garg, Millie, Needham, Bronwen, Pickford, Russell, Jaffe, Adam, Thomas, Torsten, Ooi, Chee Y.

    Published in Scientific reports (09-12-2019)
    “…Intestinal dysbiosis has been observed in children with cystic fibrosis (CF), yet the functional consequences are poorly understood. We investigated the…”
    Get full text
    Journal Article
  7. 7

    Probiotics for people with cystic fibrosis by Coffey, Michael J, Garg, Millie, Homaira, Nusrat, Jaffe, Adam, Ooi, Chee Y

    Published in Cochrane database of systematic reviews (22-01-2020)
    “…Cystic fibrosis (CF) is a multisystem disease and the importance of growth and nutrition has been well established, given its implications for lung function…”
    Get more information
    Journal Article
  8. 8

    Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation by Ooi, Chee Y., Syed, Saad A., Rossi, Laura, Garg, Millie, Needham, Bronwen, Avolio, Julie, Young, Kelsey, Surette, Michael G., Gonska, Tanja

    Published in Scientific reports (13-12-2018)
    “…Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Next to progressive airway disease, CF is…”
    Get full text
    Journal Article
  9. 9

    Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey by Ward, Anastasia, Mauleon, Ramil, Arellano, Jacinta, Ooi, Chee Y., Rosic, Nedeljka

    Published in Pediatric pulmonology (01-07-2023)
    “…Background The objective of this study was to conduct a web‐based questionnaire to investigate self‐reported phenotypes and disease burdens of individuals…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures British Committee for Standards in Haematology by CHEE, Y. L, CRAWFORD, J. C, WATSON, H. G, GREAVES, M

    Published in British journal of haematology (01-03-2008)
    “…Unselected coagulation testing is widely practiced in the process of assessing bleeding risk prior to surgery. This may delay surgery inappropriately and cause…”
    Get full text
    Journal Article
  12. 12

    Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis by Cecchetti, Martina, Scarallo, Luca, Lionetti, Paolo, Ooi, Chee Y., Terlizzi, Vito

    Published in Paediatric respiratory reviews (20-09-2024)
    “…•An analysis on the impact of highly effective modulator therapy on gastrointestinal symptoms and features in pwCF.•The benefits of…”
    Get full text
    Journal Article
  13. 13

    Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities by Singh, Harveen, Coffey, Michael J, Ooi, Chee Y

    “…Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of…”
    Get full text
    Journal Article
  14. 14

    Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis by Nielsen, Shaun, Needham, Bronwen, Leach, Steven T., Day, Andrew S., Jaffe, Adam, Thomas, Torsten, Ooi, Chee Y.

    Published in Scientific reports (04-05-2016)
    “…Cystic fibrosis (CF) is a genetic disorder that leads to formation of thick epithelial secretions in affected organs. Chronic microbial infections associated…”
    Get full text
    Journal Article
  15. 15

    Resuscitating Cardiopulmonary Resuscitation Training in a Virtual Reality: Prospective Interventional Study by Perron, Janaya Elizabeth, Coffey, Michael Jonathon, Lovell-Simons, Andrew, Dominguez, Luis, King, Mark E, Ooi, Chee Y

    Published in Journal of medical Internet research (29-07-2021)
    “…Background Simulation-based technologies are emerging to enhance medical education in the digital era. However, there is limited data for the use of virtual…”
    Get full text
    Journal Article
  16. 16

    What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? by van Dorst, Josie M, Tam, Rachel Y, Ooi, Chee Y

    Published in Nutrients (22-01-2022)
    “…Cystic fibrosis (CF) is a life-shortening genetic disorder that affects the cystic fibrosis transmembrane conductance regulator (CFTR) protein. In the…”
    Get full text
    Journal Article
  17. 17

    Pancreatitis and pancreatic cystosis in Cystic Fibrosis by Freeman, A. Jay, Ooi, Chee Y.

    Published in Journal of cystic fibrosis (01-11-2017)
    “…The pathologic effects of an altered cystic fibrosis transmembrane receptor (CFTR) protein on the exocrine pancreas is ubiquitous and of varying severity. In…”
    Get full text
    Journal Article
  18. 18

    Body composition and body mass index measures from 8 to 18 years old in children with cystic fibrosis by Tran, Jade K, Ooi, Chee Y, Blazek, Katrina, Katz, Tamarah

    Published in Journal of cystic fibrosis (01-09-2023)
    “…Historically, body mass index (BMI) >50th percentile has represented optimal nutritional status in children with cystic fibrosis (CF) due to its positive…”
    Get full text
    Journal Article
  19. 19

    Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis by Girard, L., Koh, Y. J., Koh, L. P., Chee, Y. L., Chan, H. L., Lee, J., de Mel, S., Poon, L. M., Samuel, M.

    Published in Bone marrow transplantation (Basingstoke) (01-06-2024)
    “…There is currently no consensus on the role of upfront autologous transplantation (ASCT) for patients with peripheral T-cell lymphomas (PTCL), especially in…”
    Get full text
    Journal Article
  20. 20

    Cystic Fibrosis‐related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities by Singh, Harveen, Coffey, Michael J., Ooi, Chee Y.

    “…ABSTRACT Background: Cystic fibrosis‐related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and…”
    Get full text
    Journal Article